News
What Makes Wayfair (W) a New Strong Buy Stock
Wayfair (W) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one
Here's Why Lumentum (LITE) is a Great Momentum Stock to Buy
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Mesoblast Limited (MESO) Is Up 40.59% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Annaly (NLY) Upgraded to Strong Buy: Here's What You Should Know
Annaly Capital Management (NLY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings
Are You Looking for a Top Momentum Pick? Why Citigroup (C) is a Great Choice
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Monarch Casino (MCRI) is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
SPX Technologies (SPXC) Is Up 3.33% in One Week: What You Should Know
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Metropolitan Bank Holding Corp. (MCB) Is Up 6.23% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
OverseaChinese Banking (OVCHY) Upgraded to Buy: Here's Why
Oversea-Chinese Banking Corporation Limited (OVCHY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward
Are You Looking for a Top Momentum Pick? Why Wolverine World Wide (WWW) is a Great Choice
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Morgan Stanley (MS) Upgraded to Buy: What Does It Mean for the Stock?
Investors might want to bet on Morgan Stanley (MS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --
Texas Capital (TCBI) Is Up 3.91% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Netflix (NFLX) Upgraded to Strong Buy: Here's Why
Netflix (NFLX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --
First Financial Corp. (THFF) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, First Financial Corp. (THFF) reported revenue of $63.05 million, up 28.2% over the same period last year. EPS came in at $1.57, compared to $0.96 in the year-ago
Seagate (STX) is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Flowserve (FLS) Upgraded to Strong Buy: What Does It Mean for the Stock?
Investors might want to bet on Flowserve (FLS), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one
TE Connectivity (TEL) Is Up 1.05% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
All You Need to Know About Maximus (MMS) Rating Upgrade to Strong Buy
Investors might want to bet on Maximus (MMS), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of
Is Ouster Well-Poised to Capture the USD 14B Robotics LiDAR Market?
Ouster Inc. OUST is targeting a $70 billion global LiDAR market that spans automotive, industrial, robotics, and smart infrastructure, with robotics alone accounting for a $14 billion addressable
ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside
ImmuCell Corporation ICCC has received a recommendation upgrade to “Outperform,” driven by consistent execution across its sales and gross margin profile, alongside emerging strategic optionality
Super Micro Computer's HPC Solutions Propel Server Growth: What's Next?
Super Micro Computer’s SMCI server and storage segment has experienced massive traction in recent times. The recent growth has primarily been fueled by demand in high performance computing (HPC) and
Zacks Initiates Coverage of Blue Ridge Bankshares With Outperform Recommendation
Zacks Investment Research has recently initiated coverage of Blue Ridge Bankshares, Inc. BRBS, assigning an "Outperform" recommendation to the company's shares. This bullish stance reflects the
AGNC Investment Q2 Earnings Miss Estimates, Book Value Declines Y/Y
AGNC Investment Corp.’s AGNC second-quarter 2025 net spread and dollar roll income per common share (excluding estimated "catch-up" premium amortization benefit) of 38 cents missed the Zacks
JNJ Seeks FDA Approval for Oral Psoriasis Drug Icotrokinra
Johnson & Johnson JNJ announced that it has submitted a new drug application (NDA) to the FDA seeking approval for its investigational oral peptide, icotrokinra, for treating moderate-to-severe
3 Reasons Why Investors Should Stay Away From Alibaba Stock Right Now
Alibaba Group BABA presents a concerning investment picture that should give potential investors serious pause. While the Chinese e-commerce giant reported revenue growth of 7% year over year to


